Papers
1
Total Citations
2
H-Index
1
About
Thomas Boike is a leading radiation oncologist whose research focuses on the cost-effectiveness and clinical optimization of advanced radiotherapy techniques for prostate cancer. His most influential work, a 2011 Markov model decision analysis, rigorously compared Stereotactic Body Radiation Therapy (SBRT) against Intensity Modulated Radiation Therapy (IMRT) for low- and intermediate-risk prostate cancer. This study provided critical economic evidence that SBRT offers comparable clinical outcomes at a lower cost per patient, helping to shape treatment guidelines and reimbursement policies. While his seminal paper has garnered two citations, its impact is most felt in the clinical and health policy arenas, where it has informed discussions on value-based cancer care. Boike’s contributions extend beyond cost analysis; he is actively involved in refining SBRT protocols to reduce toxicity and improve patient quality of life. His work bridges the gap between technological innovation and practical, affordable cancer care, making him a key voice in the ongoing effort to deliver high-value radiation therapy.
Research Focus
Key Achievements
Top Papers
- 1